JPRN-UMIN000015825已完成未知
Can Immunohistochemical markers be a prognostic factors in malignant pleural mesothelioma patients? - Can Immunohistochemical markers be a prognostic factors in malignant pleural mesothelioma patients?
Hyogo Prefectural Amagasaki Hospital0 个研究点目标入组 350 人开始时间: 2014年12月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with simultaneous multiple cancer Patients diagnosed with tissue type other than a biphasic or epitherial mesotherioma Patients who had been diagnosed with autopsy
研究者
相似试验
Unknown
不适用
Role of Geminin and Mcm-2 in Prognosis of Renal Cell CarcinomaRenal Cell CarcinomaNCT03692533Assiut University80
招募中
不适用
Determining prognostic immune markers in patients with ovarian cancer * a prospective explorative cohort study.Ovarian cancerNL-OMON48676eids Universitair Medisch Centrum300
尚未招募
不适用
Immunohematogical markers in Graves diseaseCTRI/2021/12/038899Jayanthy Ramesh
尚未招募
不适用
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000047162Kobe University114
尚未招募
不适用
se of immunohistochemistry and direct immunofluorescence in diagnosis of primary cicatricial alopeciaCTRI/2020/07/026308Maulana Azad Medical College